Theratechnologies Inc. Files 6-K Report
| Field | Detail |
|---|---|
| Company | Theratechnologies Inc. |
| Form Type | 6-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, press-release
TL;DR
Theratechnologies filed a 6-K, check the press release for deets.
AI Summary
Theratechnologies Inc. filed a Form 6-K on April 15, 2025, reporting a press release dated April 11, 2025. The filing does not contain specific financial figures or operational updates beyond the announcement of the press release.
Why It Matters
This filing indicates Theratechnologies Inc. is providing an update to the SEC, likely related to recent business developments or announcements that are material to investors.
Risk Assessment
Risk Level: low — The filing is a routine report of a foreign private issuer and does not contain new financial data or significant operational changes that would immediately impact risk.
Key Players & Entities
- Theratechnologies Inc. (company) — Registrant
- April 15, 2025 (date) — Filing Date
- April 11, 2025 (date) — Press Release Date
- Jocelyn Lafond (person) — General Counsel and Corporate Secretary
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report a press release dated April 11, 2025, by Theratechnologies Inc. to the U.S. Securities and Exchange Commission.
What is the filing date of this report?
This report was filed on April 15, 2025.
Who signed this report on behalf of Theratechnologies Inc.?
The report was signed by Jocelyn Lafond, General Counsel and Corporate Secretary, on behalf of Theratechnologies Inc.
What is the SIC code for Theratechnologies Inc.?
The Standard Industrial Classification (SIC) code for Theratechnologies Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Does this filing include annual report information?
No, this filing is a Form 6-K, which is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. It indicates whether the registrant files annual reports under Form 20-F or Form 40-F, and in this case, it checks the box for Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 15, 2025 by Jocelyn Lafond regarding Theratechnologies Inc..